癌症治疗中的表观遗传药物
Amila Suraweera1, Kenneth J O'Byrne2,3, Derek J Richard2
1School of Biomedical Sciences, Centre for Genomics and Personalised Health, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, QLD, 4059, Australia. amila.suraweera@qut.edu.au.
Cancer metastasis reviews
|February 26, 2025
概括
表观遗传药物 (epi-药物) 通过向DNA修饰,提供有前途的癌症治疗. 结合化学疗法和药物治疗显示出潜力,正在进行针对个性化治疗和改善药物输送的研究.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 遗传和表观遗传DNA修饰在癌症发展中至关重要.
- 表观遗传变化,包括DNA甲基化和基因素修饰,改变基因表达,并且是可逆的.
- 癌症中失调的表观遗传过程提供了治疗机会.
研究的目的:
- 审查表观遗传药物 (epi药物) 在癌症治疗中的作用.
- 探索目前和未来的应用,特别是在组合疗法.
- 讨论挑战,副作用,和进步在药开发和交付.
主要方法:
- 关于表观遗传修饰及其在癌症中的作用的现有文献的综述.
- 对各种类型的药物 (DNMTi,HDACi,HMTi,BETi) 疗效的临床数据的分析.
- 探索涉及药和常规化疗的组合策略.
主要成果:
- 抗癌药物已经证明了作为抗癌药物的临床成功.
- 与标准化疗剂的组合疗法显示出有前途的抗癌效果.
- 新的传递方法和表观遗传生物标志物正在出现,用于个性化癌症治疗.
结论:
- 治疗药物是有价值的治疗点和瘤学中的药物.
- 组合策略和个性化方法是提高药疗效和降低毒性的关键.
- 对新型传递系统和生物标志物的进一步研究将改善癌症治疗结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


